Researchers have found that central body fat, especially around the abdomen, is more strongly linked to psoriasis risk than ...

Psoriasis is often considered to be a skin condition, but it’s actually a systemic disease that can lead to symptoms such as ...

The 0.3% foam formulation of roflumilast was previously approved for the treatment of seborrheic dermatitis in adults and ...

The U.S. Food and Drug Administration has approved Zoryve (roflumilast) topical foam 0.3 percent for the treatment of plaque ...

LONDON, GREATER LONDON, UNITED KINGDOM, May 23, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts ...

1998; Helwig, 2000; Stein, 2000). Psoriasis affects 2% of the U.S. population, accounting for 10% of outpatient visits to dermatologists (Thompson, Feldman, & Fleischer, 1998). In a university ...

The approval was supported by data from 2 randomized, double-blind, vehicle-controlled trials that included 736 patients aged 12 years and older with mild to severe plaque psoriasis of the scalp and ...

See what moon phase it is tonight and find out when you can see the rest of the moon phases for 2025. Today, May 26, 2025, the moon is 29 days old and is in the New Moon phase of its lunar cycle ...

Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...

Hidradenitis suppurativa (HS) is a chronic skin condition that causes small lumps under your skin. Treatment can involve home care, including warm compresses and dietary changes. Hidradenitis ...

BMS has previously said it reckons Sotyktu could become a $4 billion seller at its peak, fuelled by head-to-head studies showing it was more effective at treating moderate-to-severe psoriasis than ...